1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CIPLA LTD.
1392.30 -5.20 (-0.37%)
1.7M
NSE+BSE Volume

NSE 19 Jan, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Analyst Downgrade
Nuvama downgrades Cipla to a 'Reduce' rating; cuts the target price to Rs 1,360 See details


Cipla Earnings/Conference Calls

Cipla earnings concalls and investor presentations

641 Votes:
Buy 75.82%
Sell 13.73%
Hold 10.45%
BUY
SELL
HOLD
Accumulate SEE REPORTS >
All reports of CIPLA